biogen
The Senior Director, Immunology Early Development Strategy & Innovation leads strategic partnerships and external innovation within the Immunology Development Unit at Biogen. This role focuses on advancing differentiated opportunities for patients with immune-mediated diseases by bridging scientific insight, clinical development, and enterprise strategy. The position requires aligning cross-functional stakeholders to drive high-quality decisions and execution across the research-to-development pipeline.
Headquarters
Cambridge, Massachusetts, United States
Company Size
5001-10000 employees
Founded
1978
Biogen is a leading biotechnology company that pioneers innovative science to develop new medicines aimed at transforming patients’ lives while creating value for shareholders and communities. It applies a deep understanding of human biology and leverages multiple modalities to advance first-in-class therapies that deliver superior clinical outcomes. Biogen balances bold scientific risk-taking with return-on-investment discipline to drive long-term growth.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biogen.
75% above the average for this role
Director, Immunology Scientific Innovation
AstraZeneca
Executive Director, Research – Integrative Sciences — Immunology
Bristol Myers Squibb
Vice President, Therapeutics Immunology
Moderna
Medical Director, Gastroenterology, Early Clinical Development
Roche
Associate Vice President, External Innovation – Immunology
Eli Lilly and Company
Global Program Head, Immunology
Regeneron Pharmaceuticals